Total Payments
$13,717
2024 Payments
$2,489
Companies
27
Transactions
417
Medicare Patients
981
Medicare Billing
$160,727
Payment Breakdown by Category
Food & Beverage$7,128 (52.0%)
Consulting$4,600 (33.5%)
Travel$1,861 (13.6%)
Education$127.70 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,128 | 408 | 52.0% |
| Consulting Fee | $4,600 | 1 | 33.5% |
| Travel and Lodging | $1,861 | 3 | 13.6% |
| Education | $127.70 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $7,587 | 60 | $0 (2024) |
| ABBVIE INC. | $992.76 | 48 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $673.15 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $594.72 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $505.54 | 23 | $0 (2024) |
| Lundbeck LLC | $470.98 | 28 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $429.69 | 33 | $0 (2024) |
| ITI, Inc. | $424.87 | 25 | $0 (2023) |
| Merck Sharp & Dohme LLC | $290.07 | 16 | $0 (2023) |
| Almatica Pharma LLC | $275.44 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,489 | 125 | Alkermes, Inc. ($428.54) |
| 2023 | $2,364 | 141 | ABBVIE INC. ($422.85) |
| 2022 | $8,675 | 140 | Alkermes, Inc. ($6,917) |
| 2021 | $188.77 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($50.96) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: CNS | ||||||
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: CNS | ||||||
| 10/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: CNS | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $118.54 | General |
| Category: CNS | ||||||
| 10/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Neuropsychiatry | ||||||
| 10/08/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 352 | 892 | $141,668 | $63,807 |
| 2022 | 3 | 427 | 1,083 | $161,633 | $75,169 |
| 2021 | 2 | 202 | 280 | $40,780 | $21,751 |
Total Patients
981
Total Services
2,255
Medicare Billing
$160,727
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 594 | $77,805 | $33,452 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 199 | $37,725 | $18,058 | 47.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 97 | 99 | $26,138 | $12,297 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 282 | 891 | $115,830 | $53,186 | 45.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 113 | 113 | $31,188 | $14,880 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 79 | $14,615 | $7,104 | 48.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 172 | 250 | $32,500 | $17,231 | 53.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 30 | 30 | $8,280 | $4,520 | 54.6% |
About Dr. Christopher Harris, DO
Dr. Christopher Harris, DO is a Psychiatry healthcare provider based in New Bern, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2014. The National Provider Identifier (NPI) number assigned to this provider is 1851716831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Harris, DO has received a total of $13,717 in payments from pharmaceutical and medical device companies, with $2,489 received in 2024. These payments were reported across 417 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,128).
As a Medicare-enrolled provider, Harris has provided services to 981 Medicare beneficiaries, totaling 2,255 services with total Medicare billing of $160,727. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location New Bern, NC
- Active Since 02/27/2014
- Last Updated 01/19/2026
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851716831
Products in Payments
- LYBALVI (Drug) $6,920
- VRAYLAR (Drug) $992.76
- REXULTI (Drug) $847.81
- ARISTADA (Drug) $666.57
- CAPLYTA (Drug) $634.99
- HETLIOZ (Drug) $370.26
- SPRAVATO (Drug) $339.18
- BELSOMRA (Drug) $290.07
- INVEGA SUSTENNA (Drug) $255.54
- ABILIFY MAINTENA (Drug) $228.94
- UZEDY (Drug) $225.98
- TRINTELLIX (Drug) $169.00
- Auvelity (Drug) $165.58
- Azstarys (Drug) $153.82
- Adzenys XR-ODT (Drug) $129.72
- CITALOPRAM (Drug) $115.82
- INGREZZA (Drug) $109.80
- VYVANSE (Drug) $102.56
- JORNAY PM (Drug) $92.81
- LOREEV XR (Drug) $82.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.